Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuria.
Postma
Maarten J
MJ
Boersma
Cornelis
C
Gansevoort
Ron T
RT
D000419:Albuminuria / Q000175:diagnosis* / Q000191:economics / Q000453:epidemiology; D003362:Cost-Benefit Analysis; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy / Q000191:economics; D003928:Diabetic Nephropathies / Q000188:drug therapy / Q000191:economics / Q000209:etiology; D017850:Economics, Pharmaceutical / Q000639:trends*; D006801:Humans; D009398:Nephrology / Q000191:economics*; D011379:Prognosis